This is a past event. Registration is closed. View other Parenteral Drug Association - Asia Pacific office events.
Juliana Gutierrez (Scientific Affairs Manager, Pharma Quality Control ASPAC at bioMérieux)

Juliana Gutierrez

Scientific Affairs Manager, Pharma Quality Control ASPAC at bioMérieux

Dr. Juliana Gutierrez is Scientific Affairs Manager at bioMérieux, where she offers her scientific expertise and support to the bioMérieux Pharma Quality Control segment across Asia. With over 8 years of experience in Asia, Juliana has held various roles, starting in Japan as Scientific Affairs and more recently in Singapore as Regional Marketing. She holds a PhD in Molecular Biology from the École Normale Supérieure de Lyon, France, and has authored several peer-reviewed papers in biology. Juliana is also a frequent guest speaker at international conferences.

Gilberto Dalmaso (Pharmaceutical Consultant at GDM Pharma Consulting)

Gilberto Dalmaso

Pharmaceutical Consultant at GDM Pharma Consulting

Gilberto Dalmaso has over 35 years’ experience in pharmaceutical microbiology and sterility assurance, primarily with GlaxoSmithKline (GSK) where he started in 1984 with Glaxo Verona (Italy). During his distinguished career at GSK he led a series of technology-driven process improvements using scientific methods, while achieving GMP compliance and regulatory approvals.

Over his last five years with GSK, Gilberto led a series of initiatives implementing Process Analytical Technologies (PAT) and Rapid Microbial Methods (RMM) that improve quality and process understanding while yielding significant cost savings. In 2003, his laboratory gained the distinction of obtaining the world’s first rapid microbial PAT approval from the US FDA. In 2005, he obtained the first approval in Italy for parametric release of terminally sterilized products. In 2008, he obtained the first FDA approval for microbiological real-time release for a non-sterile clean liquid product.

Today Gilberto is a Pharmaceutical Consultant. In this role he collaborates and consults with pharmaceutical companies to develop and implement science-based strategies and processes that utilize Quality by Design (QbD) principles to monitor, control, and improve the chemical, physical, and microbiological state of various production processes.